Annual Results Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Net Sales
580.55
510.31
472.12
424.19
386.49
366.15
361.64
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
580.55
510.31
472.12
424.19
386.49
366.15
361.64
Raw Material Cost
201.12
177.00
158.48
123.43
133.73
113.23
91.55
Purchase of Finished goods
82.91
68.64
73.67
70.31
57.60
51.69
103.94
(Increase) / Decrease In Stocks
-5.70
-4.24
-13.57
3.99
-8.41
10.46
-2.98
Employee Cost
102.90
93.16
79.72
63.26
58.65
51.90
51.15
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.00
0.01
-0.01
0.00
64.63
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
99.40
86.54
78.34
76.01
79.39
71.63
1.02
Total Expenditure (Excl Depreciation)
480.64
421.10
376.64
337.01
320.95
298.91
309.32
Operating Profit (PBDIT) excl Other Income
99.91
89.21
95.48
87.18
65.54
67.24
52.32
Other Income
34.42
22.47
10.00
5.66
11.04
5.63
5.45
Operating Profit (PBDIT)
134.33
111.68
105.48
92.84
76.58
72.87
57.77
Interest
1.46
2.03
1.45
1.56
2.02
4.00
5.41
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
132.87
109.65
104.03
91.28
74.56
68.87
52.36
Depreciation
10.62
9.17
8.09
7.56
7.33
6.68
6.11
Profit Before Tax
122.24
100.48
95.94
83.72
67.23
62.19
46.25
Tax
28.94
27.58
26.58
21.47
15.77
13.46
11.60
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
93.30
72.90
69.36
62.25
51.47
48.74
34.65
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
93.30
72.90
69.36
62.25
51.47
48.74
34.65
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
-0.03
-0.03
-0.03
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
93.30
72.90
69.36
62.25
51.44
48.71
34.62
Equity Capital
20.03
20.03
20.03
20.03
20.00
20.00
20.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
572.81
482.44
412.85
346.36
293.09
249.34
204.22
Earnings per share (EPS)
46.58
36.4
34.63
31.08
25.72
24.36
17.31
Diluted Earnings per share
46.58
36.4
34.63
31.07
25.72
24.36
17.31
Operating Profit Margin (Excl OI)
17.21%
17.48%
20.22%
20.55%
16.96%
18.36%
14.47%
Gross Profit Margin
22.89%
21.49%
22.03%
21.52%
19.29%
18.81%
14.48%
PAT Margin
16.07%
14.29%
14.69%
14.68%
13.32%
13.31%
9.58%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 13.76% vs 8.09% in Mar 2023
Consolidate Net Profit
YoY Growth in year ended Mar 2024 is 27.98% vs 5.10% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 11.99% vs -6.57% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is -28.08% vs 40.00% in Mar 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2024 has fallen from Mar 2023
Compare Annual Results Of Lincoln Pharma. With
Figures in Rs cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
580.55
10,334.77
-9,754.22
-94.38%
Other Operating Income
0.00
0.00
0.00
Total Operating income
580.55
10,334.77
-9,754.22
-94.38%
Raw Material Cost
201.12
1,853.52
-1,652.40
-89.15%
Purchase of Finished goods
82.91
1,409.85
-1,326.94
-94.12%
(Increase) / Decrease In Stocks
-5.70
-53.67
47.97
89.38%
Employee Cost
102.90
2,274.73
-2,171.83
-95.48%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
99.40
2,315.28
-2,215.88
-95.71%
Total Expenditure (Excl Depreciation)
480.64
7,799.71
-7,319.07
-93.84%
Operating Profit (PBDIT) excl Other Income
99.91
2,535.06
-2,435.15
-96.06%
Other Income
34.42
280.86
-246.44
-87.74%
Operating Profit (PBDIT)
134.33
2,815.92
-2,681.59
-95.23%
Interest
1.46
33.53
-32.07
-95.65%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
132.87
2,782.39
-2,649.52
-95.22%
Depreciation
10.62
398.25
-387.63
-97.33%
Profit Before Tax
122.24
2,384.14
-2,261.90
-94.87%
Tax
28.94
457.58
-428.64
-93.68%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
93.30
1,926.56
-1,833.26
-95.16%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
93.30
1,926.56
-1,833.26
-95.16%
Share in Profit of Associates
0.00
15.21
-15.21
-100.00%
Minority Interest
0.00
-28.87
28.87
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
93.30
1,912.90
-1,819.60
-95.12%
Equity Capital
20.03
40.06
-20.03
-50.00%
Face Value
10.00
1.00
0.00
Reserves
572.81
9,323.03
-8,750.22
-93.86%
Earnings per share (EPS)
46.58
47.75
-1.17
-2.45%
Diluted Earnings per share
46.58
47.68
-1.10
-2.31%
Operating Profit Margin (Excl OI)
17.21%
24.53%
0.00
-7.32%
Gross Profit Margin
22.89%
26.92%
0.00
-4.03%
PAT Margin
16.07%
18.79%
0.00
-2.72%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 580.55 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 13.76% vs 8.09% in Mar 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 93.30 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 27.98% vs 5.10% in Mar 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 99.91 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 11.99% vs -6.57% in Mar 2023
Annual - Interest
Interest 1.46 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -28.08% vs 40.00% in Mar 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.21%
in Mar 2024Figures in Rs %
YoY Growth in year ended Mar 2024 has fallen from Mar 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
